Global Nanomaterials In Personalized Medicine Market Expected To Reach $1.07 Billion By 2030 With 8.1% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Nanomaterials In Personalized Medicine Market Projected To Reach By 2030?
The market size for nanomaterials in personalized medicine has seen rapid expansion over recent years. This sector is anticipated to increase from $392.97 billion in 2025 to $438.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be attributed to several factors including advancements in genomics and molecular biology, the rising adoption of targeted therapies, the expansion of translational medical research, the availability of advanced nanofabrication techniques, and the growth of academic-industry collaborations.
The market size for nanomaterials in personalized medicine is set to undergo significant expansion in the coming years. It is projected to climb to $674.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This anticipated growth throughout the forecast period stems from factors such as increasing demand for customized healthcare solutions, greater investment in precision medicine programs, the wider application of nanomaterials in diagnostics and imaging, an intensified focus on minimizing therapy side effects, and continuous innovation in nano-enabled medical technologies. Prominent trends for the forecast period include the expanding use of targeted nanomaterials for individualized therapies, the rising integration of molecular diagnostics with nanotechnology, a growing adoption of nanomaterials in precise drug delivery, the broadening scope of nanotechnology in regenerative medicine, and an increased emphasis on patient-specific treatment outcomes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp
What Key Factors Are Affecting The Nanomaterials In Personalized Medicine Market Demand?
The burgeoning need for personalized medicine is anticipated to fuel the expansion of the nanomaterials in personalized medicine market in the future. Personalized medicine represents a medical strategy focused on customizing treatments for individual patients, considering their genetic makeup, environmental influences, and lifestyle elements to enhance results and refine care. The surge in personalized medicine’s popularity stems from progress in genomic technologies, facilitating the accurate detection of genetic differences and the creation of bespoke treatments for individuals. Nanomaterials in personalized medicine elevate personalized medicine by facilitating targeted, patient-specific therapeutic interventions, thereby boosting treatment effectiveness and safety. These materials permit the exact administration of drugs, genes, or RNA, consequently diminishing adverse effects and optimizing therapeutic results. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the escalating need for personalized medicine is propelling the expansion of the nanomaterials in personalized medicine market.
What Are The Main Segments Within The Nanomaterials In Personalized Medicine Market Segment Structure?
The nanomaterials in personalized medicine market covered in this report is segmented –
1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles
What Trends Are Shaping The Future Of The Nanomaterials In Personalized Medicine Market?
Companies operating within the nanomaterials in personalized medicine market are increasingly focusing on forming strategic collaborations to expedite clinical progress, broaden therapeutic applications, and reduce time to market, all while complying with evolving regulatory standards. These strategic partnerships involve organizations or institutions combining their expertise and resources to accelerate innovation and expand opportunities in personalized medicine. For instance, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, collaborated with Integrated DNA Technologies Inc., a US-based genomics solutions provider. They jointly launched a personalized CRISPR gene-editing therapy delivery, leveraging their lipid nanoparticles platform, which was used to treat a single baby with a rare genetic disease. This treatment featured precisely targeted CRISPR payloads, bespoke dose tuning, and rapid custom formulation. This innovation accelerates one-off, highly individualized treatments, enhancing therapeutic precision and patient outcomes, though it also presents challenges in terms of scalable manufacturing, stringent regulatory customization, and ultra-low-volume production.
Who Are The Companies Participating In The Nanomaterials In Personalized Medicine Market?
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
Get The Full Nanomaterials In Personalized Medicine Market Report:
Which Geographic Region Dominates The Nanomaterials In Personalized Medicine Market?
North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nanomaterials In Personalized Medicine Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2026, By The Business Research Company
Nanomaterials In Cosmetic And Personal Care Market Report 2026
Nanomedicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report
Healthcare Nanotechnology Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
